Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.
Gregory A. Low, RPh, PhD
Advertisement
Articles by Gregory A. Low, RPh, PhD
Advertisement
Latest Updated Articles
- Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control
Published: May 12th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
